Multi-dose vial management
Multi Systemic Infectious Diseases Syndrome
Multi drug Resistant Tuberculosis (MDR-TB)
Mullen BA, Cook K, Moore RD, Rand C, Galai N, McCaul ME, Glass S, Oursler KK, Lucas GM. Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs. BMC Infect Dis. 2011;11: p. 45.
Mucormycosis in paediatric patients: demographics, risk factors and
MTFCF – Lead
Mt. Dandenong Pre School Inc. HIV/Aids and Hepatitis B Policy Date
MS_Word ~ 493 KB
MSU Athletic Training Program Facts Sheet and Waiver for
MSU ATEP Facts Sheet and Waiver for Tuberculosis and Hepatitis B
MSU AT-Program Facts Sheet and Waiver for Tuberculosis and
MSK 410 Block Educational Framework (Week 1)
MSK 225 Block Educational Framework (Week 1)
MSH-UHN Antimicrobial Stewardship Clinical Summaries
MSDS_PIV - ViraTree
MSDS for Hydrogen Peroxide, 50%
MSDS for Hydrogen Peroxide 35%
MSdoc, 113KB
msdoc - Rexano
MSc/PGD/PGC in Infection (part
MSc. TID - University of Nairobi Institute of Tropical and Infectious